secwatch / observer

Heartflow, Inc. — fact timeline

Source-grounded facts extracted from Heartflow, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

HTFL Heartflow, Inc. JSON
Shareholder Votes

Heartflow, Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“2. The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved by the following vote: For Against Abstained Broker Non-Votes 68,735,861 717,413 130,088 N/A”
Shareholder Votes

Heartflow, Inc. shareholders approved Election of Class I directors at the 2026-06-16 meeting.

“1. Each of the following Class I director nominees of the Company was elected to serve on the Company’s board of directors for a three-year term expiring at the Company’s 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified by the following vote: Nominee For Withheld Broker Non-Votes Julie A. Cullivan 51,986,481 6,046,730 11,550,151 John C.M. Farquhar 52,277,825 5,755,386 11,550,151”
Earnings Releases

Heartflow, Inc. reported the quarter and full year ended December 31, 2025 results: revenue $49.1 million, net income $(0.29) net loss per share.

“artery disease (CAD), today reported financial results for the fourth quarter and full year ended Dec ember 3 1 , 2025.  Fourth Quarter 2025 Highlights " Total revenue of $49.1 million, a 40% increase year-over-year " Gross margin of 79.5%, non-GAAP gross margin of 79.9% " Net operating loss of $17. 8 million, non-GAAP net operating loss of $12.5 million " U.S.”
Governance Changes

Heartflow, Inc.: Amended and Restated Bylaws became effective upon closing of IPO (effective 2025-08-11).

“In connection with the closing of an initial public offering by Heartflow, Inc. (the “Company”) on August 11, 2025, the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws became effective.”
Governance Changes

Heartflow, Inc.: Amended and Restated Certificate of Incorporation became effective upon closing of IPO (effective 2025-08-11).

“In connection with the closing of an initial public offering by Heartflow, Inc. (the “Company”) on August 11, 2025, the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws became effective.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.